CENTRAL TRUST Co - INTERCEPT PHARMACEUTICALS IN ownership

INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 201 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q2 2019. The put-call ratio across all filers is 1.09 and the average weighting 0.3%.

Quarter-by-quarter ownership
CENTRAL TRUST Co ownership history of INTERCEPT PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2020$36,000
-23.4%
7500.0%0.00%
-33.3%
Q1 2020$47,000
-49.5%
7500.0%0.00%
-40.0%
Q4 2019$93,000
+86.0%
7500.0%0.01%
+66.7%
Q3 2019$50,000
-7.4%
7500.0%0.00%0.0%
Q2 2019$54,000
-35.7%
7500.0%0.00%
-40.0%
Q1 2019$84,000
+10.5%
7500.0%0.01%0.0%
Q4 2018$76,000
-20.0%
7500.0%0.01%
-16.7%
Q3 2018$95,000
+50.8%
7500.0%0.01%
+50.0%
Q2 2018$63,000
+37.0%
7500.0%0.00%
+33.3%
Q1 2018$46,000
+4.5%
7500.0%0.00%0.0%
Q4 2017$44,0000.0%7500.0%0.00%0.0%
Q3 2017$44,000
-51.6%
7500.0%0.00%
-50.0%
Q2 2017$91,000
+7.1%
7500.0%0.01%0.0%
Q1 2017$85,000
+4.9%
7500.0%0.01%0.0%
Q4 2016$81,000
-34.1%
7500.0%0.01%
-33.3%
Q3 2016$123,000
+15.0%
7500.0%0.01%
+12.5%
Q2 2016$107,0007500.01%
Other shareholders
INTERCEPT PHARMACEUTICALS IN shareholders Q2 2019
NameSharesValueWeighting ↓
Chicago Capital Management, LLC 185,781$4,611,56512.16%
Samsara BioCapital, LLC 640,688$11,878,3563.64%
ALPINE ASSOCIATES MANAGEMENT INC. 2,203,295$40,849,0892.14%
Versor Investments LP 378,480$7,017,0191.42%
Magnetar Financial LLC 2,407,209$44,629,6551.14%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,077,893$38,524,1360.85%
Fort Baker Capital Management LP 430,600$7,983,3240.74%
EHP Funds Inc. 84,210$1,561,2530.73%
Terrapin Asset Management, LLC 30,000$556,2000.63%
AQR Arbitrage LLC 734,970$13,626,3440.61%
View complete list of INTERCEPT PHARMACEUTICALS IN shareholders